The additive value of biomarkers to clinical risk scores in acute coronary syndrome. Are biomarkers really ready for real world usage? Response

Donald S. C. Ang, Michelle P. C. Kao, Allan D. Struthers

    Research output: Contribution to journalLetter

    Original languageEnglish
    Pages (from-to)228-228
    Number of pages1
    JournalHeart
    Volume96
    Issue number3
    DOIs
    Publication statusPublished - Feb 2010

    Keywords

    • INTERVENTIONAL STRATEGY
    • RANDOMIZED-TRIAL

    Cite this